登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
5 cm × 300 μm
Particle size:
2.7 μm
Matrix active group:
C8 (octyl) phase
Pore size:
90 Å
Matrix:
Fused-Core particle platform, superficially porous particle
产品名称
Ascentis® Express C8 HPLC 毛细管柱, 2.7 μm particle size, L × I.D. 5 cm × 300 μm
material
stainless steel column
Quality Level
agency
suitable for USP L7
product line
Ascentis®
feature
endcapped
manufacturer/tradename
Ascentis®
packaging
1 ea of
parameter
60 °C temp. range
technique(s)
HPLC: suitable, LC/MS: suitable, UHPLC-MS: suitable, UHPLC: suitable
L × I.D.
5 cm × 300 μm
surface area
135 m2/g
impurities
<5 ppm metals
matrix
Fused-Core particle platform, superficially porous particle
matrix active group
C8 (octyl) phase
particle size
2.7 μm
pore size
90 Å
operating pH range
2-9
application(s)
food and beverages
separation technique
reversed phase
Still not finding the right product?
Explore all of our products under Ascentis® Express C8 HPLC 毛细管柱
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
相关内容
Ascentis® Express Nano/Capillary Column Care & Use Sheet
Sreenivasa Rao Chitturi et al.
Journal of pharmaceutical and biomedical analysis, 55(1), 31-47 (2011-02-15)
This paper proposes a simple and selective RP-HPLC method for the determination of process impurities and degradation products (degradants) of atazanavir sulfate (ATV) drug substance. Chromatographic separation was achieved on Ascentis(®) Express C8, (150mm×4.6mm, 2.7μm) column thermostated at 30°C under
Ugandar Reddy Inugala et al.
Journal of chromatographic science, 51(5), 453-459 (2012-10-13)
This paper describes the development of a rapid, novel, stability-indicating gradient reversed-phase high-performance liquid chromatographic method and associated system suitability parameters for the analysis of naproxcinod in the presence of its related substances and degradents using a quality-by-design approach. All
Luigi Silvestro et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878(30), 3134-3142 (2010-10-20)
Quantitative methods using LC-MS/MS allow achievement of adequate sensitivity for pharmacokinetic studies with clopidogrel; three such methods, with LLOQs as low as 5 pg/mL, were developed and fully validated according to the well established FDA 2001 guidelines. The chromatographic separations
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 53997-U | 04061838535573 |